Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for WLKP and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for WLKP and 80,000+ other tickers.
See exactly how WLKP's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for WLKP and 80,000+ other tickers.
Westlake Chemical Partners LP concentrates on acquiring, developing, and operating facilities dedicated to ethylene production, along with related infrastructure, throughout the United States. These plants primarily function by converting ethane into ethylene. Furthermore, the partnership distributes a range of chemical co-products—such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen—directly to external buyers, conducting these sales through either immediate spot transactions or established contractual agreements. Westlake Chemical Partners GP LLC serves as the entity's…
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins. Top GVAS dogs are projected to deliver average net gains of 36.8% by September 2027, with risk/volatility 46% below the market. Analyst targets suggest the five lowest-priced, highest-yield GVAS stocks could outperform the broader top ten by 5.12% over the next year.
Westlake Chemical Partners NYSE: WLKP reported second-quarter 2026 net income of $14 million, or $0.40 per unit, matching its first-quarter result as stable production and sales volumes supported the partnership's fixed-margin business model.
Westlake Chemical Partners LP Common Units (WLKP) Q2 2026 Earnings Call Transcript
Declared quarterly distribution of $0.4714 per unit; 48th consecutive quarterly distribution HOUSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2026 of $14.2 million, or $0.40 per limited partner unit, which was slightly below second quarter 2025 net income of $14.6 million. Cash flows from operating activities in the second quarter of 2026 were $129.8 million, an increase of $120.7 million compared to second quarter 2025 cash flows from operating activities of $9.1 million, primarily due to higher production and sales volume and lower maintenance capital expenditures as the result of the prior year's Petro 1 turnaround.
Declared quarterly distribution of $0. 4714 per unit; 48th consecutive quarterly distribution HOUSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2026 of $14.